Showing results (91-100 of 499) with videos related to
Sort By:
Pageof 50
Clinical Endocrinology|January 25, 2006
Does growth hormone cause cancer?P J Jenkins, A Mukherjee, S M ShaletThe Journal of Clinical Endocrinology and Metabolism|August 24, 2006
Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegalyA N Paisley, C J O'Callaghan, K C Lewandowski, et al.Clinical Endocrinology|May 26, 1999
The effect of chronic hexarelin administration on the pituitary-adrenal axis and prolactinA Rahim, P A O'Neill, S M ShaletClinical Endocrinology|August 1, 1988
Changes in the qualitative and quantitative secretion of luteinizing hormone (LH) following orchidectomy in manA Tsatsoulis, S M Shalet, W R RobertsonClinical Endocrinology|December 31, 2009
d3-GHR genotype does not explain heterogeneity in GH responsiveness in hypopituitary adultsV J Moyes, D M Walker, S Owusu-Antwi, et al.The Journal of Endocrinology|January 1, 1992
Osmoregulatory adaptation in pregnancy and its disordersJ P Monson, D J WilliamsMedical and Pediatric Oncology|August 1, 1996
Gonadal function following chemotherapy for childhood Hodgkin's diseaseE J Mackie, M Radford, S M ShaletClinical Endocrinology|November 1, 1996
The assessment of growth hormone status in normal young adult males using a variety of provocative agentsA Rahim, A A Toogood, S M ShaletThe Journal of Clinical Endocrinology and Metabolism|May 20, 1998
Growth hormone status during long-term hexarelin therapyA Rahim, P A O'Neill, S M ShaletHormone Research|October 31, 2001
Sensitivity to growth hormone-the perspective. Round table discussionJ P Monson, R G RosenfeldPageof 50